» Articles » PMID: 11211904

Bacterial Translocation of Enteric Organisms in Patients with Cirrhosis

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2001 Feb 24
PMID 11211904
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: The aim of the study was to investigate the prevalence and associated risk factors for bacterial translocation in patients with cirrhosis, a mechanism involved in the pathogenesis of bacterial infections in experimental cirrhosis.

Methods: Mesenteric lymph nodes were obtained for microbiological culture from 101 patients with cirrhosis and from 35 non-cirrhotic patients.

Results: Enteric organisms were grown from mesenteric lymph nodes in 8.6% of non-cirrhotic patients. In the 79 cirrhotic patients without selective intestinal decontamination, the prevalence of bacterial translocation significantly increased according to the Child-Pugh classification: 3.4% in Child A, 8.1% in Child B and 30.8% in Child C patients (chi2 = 6.106, P < 0.05). However, translocation by Enterobacteriaceae, the organisms commonly responsible for spontaneous bacteremia and peritonitis in cirrhosis, was only observed in 25% of the cases. The prevalence of bacterial translocation in the 22 cirrhotic patients undergoing selective intestinal decontamination, all Child-Pugh class B and C, was 4.5%. The Child-Pugh score was the only independent predictive factor for bacterial translocation (odds ratio 2.22, P = 0.02).

Conclusions: Translocation of enteric organisms to mesenteric lymph nodes is increased in patients with advanced cirrhosis and is reduced to the level found in non-cirrhotic patients by selective intestinal decontamination.

Citing Articles

Safety and efficacy of a defined bacterial consortium, VE303, to treat HE.

Bloom P, Bassis C, Crossette E, Silber J, Norman J, Young V Hepatol Commun. 2025; 9(3).

PMID: 39969428 PMC: 11841841. DOI: 10.1097/HC9.0000000000000650.


Spontaneous Bacterial Peritonitis: Etiology, Microbiology, and Clinical Outcomes in Cirrhosis Patients.

U L, J D, M R, K S, Sebastian S, Khatana G Cureus. 2025; 16(12):e76679.

PMID: 39898135 PMC: 11781897. DOI: 10.7759/cureus.76679.


Ammonia and beyond - biomarkers of hepatic encephalopathy.

Gallego J, Ballester M, Fiorillo A, Casanova-Ferrer F, Lopez-Gramaje A, Urios A Metab Brain Dis. 2025; 40(1):100.

PMID: 39812958 PMC: 11735499. DOI: 10.1007/s11011-024-01512-7.


Risk factors for endogenous endophthalmitis in infectious endocarditis patients.

Shah M, Zhu A, Uppuluri A, Henry R, Zarbin M, Bhagat N Eye (Lond). 2024; 39(1):125-132.

PMID: 39402169 PMC: 11733160. DOI: 10.1038/s41433-024-03390-w.


A rare case of invasive infection and related diagnostic difficulties.

Szymanski M, Skiba M, Piasecka M, Olender A Clin Case Rep. 2024; 12(9):e9386.

PMID: 39210929 PMC: 11358030. DOI: 10.1002/ccr3.9386.